Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate/testosterone decanoate

Category:Articles with short descriptionCategory:Short description is different from Wikidata
TP/TPP/TiC/TD
Combination of
Testosterone propionateAndrogen; Anabolic steroid
Testosterone phenylpropionateAndrogen; Anabolic steroid
Testosterone isocaproateAndrogen; Anabolic steroid
Testosterone decanoateAndrogen; Anabolic steroid
Clinical data
Trade namesDurandrone Forte, Durateston, Prarbolan, Sustanon 250, Sustanon Prolongatum
Other namesTP/TPP/TiC/TD
Routes of
administration
Intramuscular injection
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Category:Pages using infobox drug with unknown parametersCategory:Infobox drug articles with non-default infobox title#Testosterone%20propionate/testosterone%20phenylpropionate/testosterone%20isocaproate/testosterone%20decanoateCategory:Articles without EBI source#*Category:Chemical pages without DrugBank identifier#*Category:Articles without KEGG source#*Category:Articles without InChI source#*Category:Multiple chemicals in Infobox drug#*Category:Multiple chemicals in an infobox that need indexing#*Category:Chemical articles with multiple CAS registry numbers#*Category:Drugs missing an ATC codeCategory:Drugs with no legal statusCategory:Articles containing unverified chemical infoboxes#*Category:Drugs that are a combination of chemicals#4

Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate/testosterone decanoate (TP/TPP/TiC/TD), also known as a Sustanon 250 (Organon), is an injectable combination medication of four testosterone esters, all of which are androgens/anabolic steroids.[1]

Pharmacology

The four testosterone esters are as follows;

Cumulatively, a 1 ml of the oil solution contains exactly 250 mg of above mentioned testosterone esters.[2][3] This particular numerical value is clearly depicted in the name of the product, Sustanon 250.[4]

They are provided as an oil solution and are administered by intramuscular injection.[5] The different testosterone esters provide for different elimination half-lives in the body. Esterification of testosterone provides for a sustained but non-linear release of testosterone hormone from the injection depot into the circulation. Sustanon 100 is administered once every 2 weeks and Sustanon 250 is administered once every 3 to 4 weeks.[6]

Sustanon is the preferred method of testosterone replacement in the United Kingdom as detailed in the British National Formulary.Category:All articles with unsourced statementsCategory:Articles with unsourced statements from November 2010[citation needed] There was a brief shortage of Sustanon 250 during late 2011, due to shifting of manufacturing site,[7] and a further shortage in mid-2012 due to manufacturing problems.Category:All articles with unsourced statementsCategory:Articles with unsourced statements from August 2016[medical citation needed]

This form of testosterone has long been a popular choice of anabolic steroid among bodybuilders while bulking.Category:All articles with unsourced statementsCategory:Articles with unsourced statements from August 2016[citation needed]

Synonyms/brands

  • Durateston
  • Durandrone Forte
  • Sustanon prolongatum
  • Prarbolan

Medical dosage

See also

References

  1. 1 2 3 4 5 PubChem. "Sustanon 250". pubchem.ncbi.nlm.nih.gov. Retrieved 2020-09-06.
  2. "NEW ZEALAND DATA SHEET-SUSTANON 250 (250 mg testosterone esters solution for injection)" (PDF). Medsafe, Ministry of Health (New Zealand). 18 June 2020.
  3. "Detailed description of the steroid drug Sustanon 250". Secrets of bodybuilding and muscles training. 2020-02-05. Retrieved 2020-09-06.
  4. "Sustanon 250 Online | 100% Real". Retrieved 2021-01-21.
  5. Area Prescribing Committee, Nottinghamshire (January 2020). "ADMINISTRATION GUIDE FOR TESTOSTERONE SUSTANON-250" (PDF). National Health Service. Archived from the original (PDF) on 2021-11-05. Retrieved 2020-09-06.
  6. Llewellyn W (2011). Anabolics. Molecular Nutrition Llc. pp. 392–398. ISBN 978-0-9828280-1-4.
  7. MEDICINES MANAGEMENT COMMITTEE, HERTFORDSHIRE (November 2011). "Testosterone undecanoate (Nebido) is recommended as an option for testosterone replacement therapy ONLY whilst Sustanon 250 and Testosterone Enantate (Nonproprietary) are unavailable" (PDF). National Health Service. Archived from the original (PDF) on 2021-04-19. Retrieved 2020-09-06.
Category:Combined androgen formulations Category:Drugs developed by Schering-Plough Category:Drugs developed by Merck & Co. Category:Testosterone esters
Category:All articles with unsourced statements Category:Articles containing unverified chemical infoboxes Category:Articles with short description Category:Articles with unsourced statements from August 2016 Category:Articles with unsourced statements from November 2010 Category:Articles without EBI source Category:Articles without InChI source Category:Articles without KEGG source Category:Chemical articles with multiple CAS registry numbers Category:Chemical pages without DrugBank identifier Category:Combined androgen formulations Category:Drugs developed by Merck & Co. Category:Drugs developed by Schering-Plough Category:Drugs missing an ATC code Category:Drugs that are a combination of chemicals Category:Drugs with no legal status Category:Infobox drug articles with non-default infobox title Category:Multiple chemicals in Infobox drug Category:Multiple chemicals in an infobox that need indexing Category:Pages using infobox drug with unknown parameters Category:Short description is different from Wikidata Category:Short description matches Wikidata Category:Testosterone esters